Healthcare Analytical Testing Services Market Worth 4.13 Billion USD by 2021 - Seite 2

In 2015, bioanalytical testing services accounted for the largest share of the global Healthcare Analytical Testing Services Market. However, the batch-release testing segment is expected to witness the highest growth in the next five years.

On the basis of samples, the raw materials segment accounted for the largest share of the global Healthcare Analytical Testing Services Market. The large share of this market segment is mainly due to factors such as increasing R&D expenditure for drug development and the presence of a large number of molecules in the pipeline.

In the end-user segment, pharmaceutical and biopharmaceutical companies accounted for the largest share of the Healthcare Analytical Testing Services Market and are expected to grow at the highest CAGR in next five years. This large share is due to the increased R&D expenditure to develop new drug molecules, growing focus on delivering high-quality products, and rising demand for analytical testing by regulators.

North America is the largest regional segment for Healthcare Analytical Testing Services Market owing to the well-established analytical testing services market. The large share of this regional segment can be attributed to factors such as high quality standards in the pharmaceutical industry, rapid growth in biosimilars and biologics market, and presence of a large pool of analytical testing providers in the region. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to the huge R&D expenditure in drug development, growing pharmaceutical and biopharmaceutical industries in the country, and growing focus of pharmaceutical companies on the market due to the low manufacturing cost advantage in India and China.

Eurofins Scientific SE (Luxembourg), WuXi PharmaTech (Cayman) Inc. (China), SGS (Switzerland), and Charles River Laboratories International Inc. (U.S.) held the major share of the Healthcare Analytical Testing Services Market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are PPD Inc. (U.S.), Exova Group Plc. (U.K.), Source BioScience Plc (U.K.), Intertek Group Plc. (U.K.), Medistri SA (Switzerland), Pace Analytical Services Inc. (U.S.), Anabiotec (Belgium), and BioReliance Corporation (U.S.).